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Introduction
About a third of the proteome in living cells is integrated into or transported across membranes, catalyzed by the ubiquitous Sec machinery which is conserved in all kingdoms of life. In prokaryotes, the Sec machinery contains the core translocon, SecYEG. Regulatory subunits including SecDF, YajC and YidC can associate with the core translocon giving rise to the SecYEG-SecDFYajC-YidC holotranslocon complex (1) (2) (3) (4) . All subunits in this heptameric holotranslocon are transmembrane proteins (3, 5) .
Heterologous expression has been instrumental to advance protein research in the life sciences, and E. coli has largely dominated the field of recombinant expression, a trend which remains unbroken to date, although mammalian and insect cell based eukaryotic expression systems have been making their impressive mark more recently (6) (7) (8) (9) . E. coli remains unsurpassed as a simple and cost effective expression host for protein production, and a very large number of plasmids and host strains are conveniently available to the research community for recombinant expression in this prokaryotic system. 3 In living cells, the catalysts of biological activity are typically not single, isolated proteins, but protein complexes which can contain many different subunits (10, 11) . Many complexes are characterized by low abundance and heterogeneity in their native hosts, which is refractory to their extraction from native source material, and necessitates recombinant overexpression to purify them in sufficient amounts for detailed mechanistic studies. The SecYEG-SecDFYajC-YidC holotranslocon transmembrane protein complex, HTL, has been discovered in E. coli membranes, where it catalyzes the transport of membrane-bound or periplasmic proteins as they emerge from the actively translating ribosome (3) (4) (5) (12) (13) (14) . A particular challenge in expressing functional complexes such as HTL can be encountered when many heterologous subunits are co-produced from individual expression cassettes, resulting in imbalanced expression levels of the individual proteins and impedes proper complex assembly. Certain subunits can be expressed either more weakly of strongly, and, occasionally, one subunit may dominate the recombinant overexpression experiment to a degree that it becomes detrimental to overall yield. As a consequence, a complex containing all subunits at their physiological stoichiometric ratios cannot be obtained. Moreover, the HTL consists of assembly blocks which by themselves can form stable entities (SecYEG, SecDF and YidC), further complicating HTL production and purification as a homogeneous, functional assembly, prenecessitating elaborate promoter and expression cassette design, tag placement and systematic trial-and-error to achieve success (13) (14) (15) . Originally, only six subunits (SecYEG, SecDF and YidC) were thought to be present in HTL and thus included in the overexpression experiments (15) . Later, a seventh subunit, YajC, was identified and added to the overexpression setup to yield complete, functional and stable heptameric HTL (12) (13) (14) .
In order to meet these challenges and to produce and purify HTL in the quality and quantity required for detailed study, we developed ACEMBL, a modular overexpression system for protein complex expression in E. coli ( Fig. 1) (15) (16) (17) . ACEMBL affords the means to assemble mono-or polycistronic expression cassettes to optimally balance expression levels and achieve properly assembled complexes with correct subunit stoichiometry. ACEMBL consists of small, custom designed expression plasmids containing all elements required for expressing recombinant proteins in E. coli as an expression host ( Fig. 1) . Two families of plasmids exist, Acceptors and Donors ( Fig. 1) . Acceptors and Donors can each contain one or several genes of interest, arranged in (i) single gene expression cassettes consisting of a promoter, a gene and a transcriptional terminator, or (ii) in the form of polycistrons where several genes are transcribed from the same promoter, or a combination of both (15) . Donors and Acceptors, each containing one or several genes of interest, are conveniently fused by Cre recombinase to yield Donor-Acceptor fusions which contain all genes that need to be co-produced. Promoters, genes and terminators are in BioBrick design (18) and exchangeable in the individual Donors and Acceptors, a feature which enabled us to test the best combinations for producing functional HTL in parallel by trial and error within a reasonable timeframe until a suitable HTL expression construct was identified ( Fig. 2) . ACEMBL can be implemented in a robotics environment (15, 16) , however, for most applications in our laboratory (including HTL) production, the manual approach, optionally with a multichannel pipette, is sufficient to achieve success. We have described earlier the conceptual use of ACEMBL to generate HTL expression constructs (13) (14) (15) . In the present contribution, we describe the principle of HTL multigene expression construct assembly which can be used as a blueprint for other transmembrane or soluble complexes. We highlight important considerations for the production and purification of functional HTL (Fig. 3) , and describe the assembly of HTL with actively transcribing ribosome nascent chain complexes (RNCs) into a RNC-HTL supercomplex ( Fig. 4 ).
Materials
We strongly recommend carrying out the design of all expression constructs in silico using a DNA cloning software of choice (i.e. VectorNTI, ApE, others). Gene synthesis has become very affordable, and we prefer synthetic genes for generating the individual genes of interest, in which internal restriction sites for subcloning into the ACEMBL Donor and Acceptor plasmids are eliminated by design. We also recommend codon optimization for expression of the genes of interest, which is a service provided at no cost from synthetic DNA suppliers, and typically includes removal of potentially problematic RNA secondary structure elements in the transcripts. If synthetic genes are used, we further recommend to additionally eliminate any restriction sites that are part of the so-called multiplication modules in the plasmids (15, 16) . This allows for maximum flexibility of gene assembly for co-expression (e.g. if purification tag placement needs to be revised in later iterations). The modular concept of ACEMBL furthermore allows transferring expression cassettes between various plasmids (15) .
All reagents are prepared using ultrapure water (Millipore Milli-Q system or equivalent; conductivity of 18.2 MΩ•cm at 25°C) and analytical grade reagents. Buffers, antibiotics and enzymes are stored at -20°C. 2. DDM solubilized purified HTL.
Generation of Donor and Acceptor plasmids for HTL subassemblies

Methods
The genes encoding for the individual subunits are designed in silico, and then inserted into 
Decide on the number of expression cassettes to be co-expressed and the Donor and
Acceptor plasmids you plan to use. 6. Create all DNA sequences in silico and validate by simulating the reading frame in the in silico plasmid sequences. 4. Transform E. coli competent cells (TOP10 or HB101 for Acceptors, pir gene containing cells for Donors; see Note 1) with ligation reaction mixture. Incubate the transformation reaction in a 37°C shaker for several hours and plate on agar plates in a dilution series to ensure optimal colony separation.
Preparation of Donor and Acceptor plasmids
Inserting genes into digested Donor or Acceptor
5. Pick colonies, grow minicultures and purify plasmids using standard procedures.
6. Identify positive clones by restriction digestion and DNA sequencing of the insert. 3. Pick colonies and inoculate 25 mL aliquots of LB medium supplemented with corresponding antibiotics. After overnight incubation, prepare Acceptor-Donor fusion plasmid using standard kits (Qiagen). Predict Acceptor-Donor fusion plasmid sequence by using web-based Cre-ACEMBLER software (21) . Check plasmids by restriction digestion using appropriate enzymes identified by restriction pattern prediction (see Note 2). 11 
Cre-LoxP fusion of Donors and Acceptor
Producing recombinant HTL
1. Grow freshly transformed E. coli C43(DE3) with ACEMBL plasmid encoding for HTL ( Fig. 2 ) in 2xYT broth with antibiotics to OD600 = 0.8.
2. Induce for 3h by adding 1 mM IPTG and 0.2% (wt/vol) arabinose.
Pellet cells by centrifugation and break cells at 25 kpsi with cell disruptor in TSG130
buffer.
Collect membrane fraction containing HTL and solubilize by rotation in TSG130
containing 2% (wt/vol) DDM for 1h at 4°C.
5.
Clarify DDM-soluble fraction by centrifugation and purify by using Ni 2+ metal affinity chromatography (column pre-equilibrated in TSG130 containing 0.1% DDM).
6. Wash column thoroughly (10 column volumes) with buffer containing 30 mM imidazole.
7. Elute bound HTL with buffer containing 500 mM imidazole.
8. Pool peak fractions and purify immediately using a S200 size exclusion column, placed in-line with a Q-Sepharose column equilibrated in TSG130 + 0.05% DDM.
9. Pool peak fractions and concentrate (50kDa cutoff Amicon filter).
10. Concentrate to 5-10mg/ml (molar extinction coefficient: HTL = 497,000 M-1cm-1 (13).
Assembling RNC-HTL supercomplex
1. Mix DDM-solubilized HTL and purified RNC FtsQ in a 25:1 molar ratio.
2. Isolate resulting RNC FtsQ -HTL supercomplex by sedimentation centrifugation through a sucrose cushion to separate unbound HTL from ribosome associated HTL as described earlier for the core translocon, SecYEG, bound to RNC (21).
Notes
1. Donors and their derivatives can only be propagated in cells that express the pir gene (such as BW23473, BW23474, or PIR1 and PIR2, Invitrogen) due to the conditional origin present on these plasmids (23) . In contrast, Acceptors and their derivatives contain regular ColE1 origin of replication and can be propagated in regular E. coli strains (TOP10, HB101, or comparable). 
